Investigator's investigational drug

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigator's investigational drug, covering 2020-05-08 to 2020-05-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia [Phase 1]

See pricing